Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0 Просмотры
• 07/04/23
0
0
встраивать
administrator
Подписчики
Earn CME for related activities: https://www.naccme.com/oln
This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.
© 2018 NACCME, an HMP Company
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии